January 22, 2015 — Cleveland HeartLab (CHL) announced that it has acquired the MIRISK cardiovascular disease (CVD) risk ...
February 10, 2014 — Traditional fingerstick screening for glucose and lipids is proving inadequate when identifying near ...
August 24, 2011 — Cleveland HeartLab Inc. (CHL), a specialty clinical laboratory and disease management company ...